Ivermectin for COVID-19: Worth a Shot? Researchers from Monash University in Australia showed that ivermectin could inhibit SARS-CoV-2
Could?
How about getting back to us when it says DOES.
Meanwhile keep lying about HCQ and letting people die needlessly. These people need to know we see right through them. THEY LIE!
“Could?
How about getting back to us when it says DOES.”
Could, as in “was able to.”
Poor writing.
RE: How about getting back to us when it says DOES.
SEE HERE:
https://nypost.com/2020/08/09/is-there-a-cure-for-anti-trump-disease-devine/
Clinical trials on his ivermectin triple therapy are about to start in California and are underway in 32 other countries.
But results using the drug off-label have been promising.
In Bangladesh, 400 patients with mild to moderate symptoms were treated and 98 percent cleared the virus within four to 14 days.
In the Dominican Republic, in 1,300 patients the average duration of infection fell from 21 days to 10 days.
And in sick patients at Broward County Medical Center in Florida, mortality fell by 48 percent.
The results have been so remarkable that the government of the most populous Indian state, Uttar Pradesh, approved the use of ivermectin for COVID-19 patients and as a prophylactic for front-line workers.
But Borody has not been able to find a drug company interested in paying for clinical trials for a cheap drug that won’t reap them profits.